Galapagos Announces Advancement of Triple Combination Therapy into Development for Cystic Fibrosis Treatment
Cystic Fibrosis, News
Galapagos NV has announced the advancement of development plans for a triple combination Cystic fibrosis (CF) therapy consisting of GLPG2665, one of the multiple C2 correctors developed by the company, corrector ... Read more